Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
28,000
Employees28,000
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
28,000
Employees28,000

AMGN Key Statistics

Market cap
150.36B
Market cap150.36B
Price-Earnings ratio
36.76
Price-Earnings ratio36.76
Dividend yield
3.29%
Dividend yield3.29%
Average volume
2.91M
Average volume2.91M
High today
$282.26
High today$282.26
Low today
$274.42
Low today$274.42
Open price
$278.47
Open price$278.47
Volume
2.26M
Volume2.26M
52 Week high
$346.85
52 Week high$346.85
52 Week low
$253.30
52 Week low$253.30

AMGN News

Benzinga 3d
Amgen, Franco-Nevada, Take-Two Interactive And More: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Brian Belski of BMO Capital Markets named Take-Two Interactive Software, Inc. TTWO as his final trade. On the earning...

Amgen, Franco-Nevada, Take-Two Interactive And More: CNBC's 'Final Trades'
TipRanks 3d
Amgen assumed at Neutral from Overweight at Cantor Fitzgerald

As previously reported, Cantor Fitzgerald downgraded Amgen (AMGN) to Neutral from Overweight with a price target of $305, down from $340, as the analyst took ov...

Analyst ratings

48%

of 31 ratings
Buy
41.9%
Hold
48.4%
Sell
9.7%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.